HSChapter 39
U.S. imports of cellulose & its chemical derivatives (nesoi) in primary forms (HS 391290) totaled $12.6M in June 2026, traded with 28 countries.
Importers of Cellulose & Its Chemical Derivatives (NESOI) in Primary Forms paid $788K in duties in June 2026 โ an effective duty rate of 6.6% on $12.0M in dutiable value, based on actual customs collections rather than the published tariff schedule. Cellulose & Its Chemical Derivatives (NESOI) in Primary Forms imports of $12.6M in June 2026 ran 16% above the year-to-date monthly average of $10.8M.
Last updated: June 2026 dataMicrocrystalline cellulose (MCC), alpha-cellulose powder, and other chemical derivatives of cellulose not classified elsewhere in heading 3912 are captured here, with the US schedule providing a dedicated line (3912900010) for alpha-cellulose in granular, microcrystalline, or powder form alongside a broader residual line (3912900090). MCC is a critical pharmaceutical excipient and food additive, making India โ the leading US supplier โ a strategically important source given its large pharmaceutical manufacturing base. Thailand and Japan are also notable suppliers, reflecting diverse end-use demand ranging from food texturizers to specialty paper and filtration media.
AI-written summary of the official U.S. Census Bureau trade figures on this page โ verify before relying on it.
The dedicated line 3912900010 covers alpha-cellulose specifically presented in granular, microcrystalline, or powder form โ the physical presentations used as pharmaceutical excipients and food additives. Other cellulose chemical derivatives that do not fit the acetate, nitrate, ether, or microcrystalline alpha-cellulose descriptions fall into the residual line 3912900090. The distinction matters because MCC is subject to FDA oversight as a food additive and pharmaceutical excipient, while other derivatives in the residual line may face different regulatory pathways.
MCC used as a pharmaceutical excipient must conform to USP monograph specifications and is subject to FDA's current Good Manufacturing Practice (cGMP) expectations for excipient suppliers. Importers should ensure the foreign manufacturer is registered with FDA, maintain a supplier qualification program, and be prepared for FDA sampling at entry. Consulting a licensed customs broker and regulatory counsel familiar with pharmaceutical excipient imports is strongly recommended.
Supplier Network
Get discovered by U.S. importers searching for HS 391290 โ Cellulose & Its Chemical Derivatives (NESOI) in Primary Forms. Be the first supplier listed.
Monthly import values over time
| Country | Imports | Exports | Balance |
|---|---|---|---|
| CHINA | $243K | $8.4M | +$8.2M |
| INDIA | $3.1M | $1.9M | -$1.2M |
| JAPAN | $1.1M | $3.5M | +$2.4M |
| NETHERLANDS | $437 | $3.3M | +$3.3M |
| MEXICO | $150K | $2.9M | +$2.7M |
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3912900010 | (ALPHA)-CELLULOSE IN GRANULAR, MICRYCRYSTAL OR PWD | $8.6M | 5.83% | 95.77% | $502K |
| 3912900090 | CELLULOSE & ITS CHEMICAL DERIV,PRIMARY FORMS,NESOI | $4.0M | 7.24% | 94.28% | $286K |
(ALPHA)-CELLULOSE IN GRANULAR, MICRYCRYSTAL OR PWD
CELLULOSE & ITS CHEMICAL DERIV,PRIMARY FORMS,NESOI
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3912900000 | CELLULOSE & ITS CHEMICAL DERIV,PRIMARY FORMS,NESOI | $34.5M |
CELLULOSE & ITS CHEMICAL DERIV,PRIMARY FORMS,NESOI
4.2M kg
ARTICLES OF PLASTICS, NESOI
HS 392690
TABLEWARE AND KITCHENWARE OF PLASTICS
HS 392410
FLOOR, WALL, ETC COVERS, VINYL CHLORIDE POLYMERS
HS 391810
HOUSEHOLD AND TOILET ARTICLES NESOI OF PLASTICS
HS 392490
SACKS & BAGS (INCL CONES) OF POLYMERS OF ETHYLENE
HS 392321
ETHYLENE-ALPHA-OLEFIN COPOLY, SPC GRAVITY <0.94
HS 390140
| Port | Imports | Exports | Balance |
|---|---|---|---|
| CHARLESTON, SC | $985K | $21.4M | +$20.4M |
| NEWARK, NJ | $5.2M | -- | -$5.2M |
| NEW YORK, NY | $642K | $3.0M | +$2.3M |